GO:0031124 mRNA 3'-end processing: Molecular Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031124 (mRNA 3'-end processing) is the biological process that forms the mature 3' end of an mRNA molecule, encompassing cleavage and polyadenylation.
• The process is executed by a large multi-protein machinery that recognizes the polyadenylation signal, cleaves the pre-mRNA, and adds a poly(A) tail.
• Core factors include CPSF, CstF, CFI, CFII, symplekin, and poly(A) polymerase, whose activities are tightly coupled to transcription and splicing.
• Dysregulation of 3'-end processing is linked to cancer, neurological disorders, and viral infections, making it a therapeutic target.
• Genotoxic stress and biomolecular condensates dynamically regulate 3'-end processing, revealing layers of cellular control.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable functional dissection of this pathway in disease contexts.
Description
mRNA 3'-end processing (GO:0031124) is a fundamental biological process that converts the 3' end of a newly transcribed pre-mRNA into a mature, polyadenylated terminus. This process is essential for mRNA stability, nuclear export, and translation, and it serves as a key regulatory step in gene expression. The reaction involves endonucleolytic cleavage of the pre-mRNA at a specific site, followed by the addition of a poly(A) tail, which is mediated by a large machinery of multi-domain proteins. Researchers study this process to understand how gene expression is controlled and how its dysregulation contributes to human disease. Recent advances have revealed that 3'-end processing is coupled to transcription, splicing, and cellular stress responses, and that it can be modulated by viral infections and biomolecular condensates. Because of its central role in mRNA biogenesis, the pathway is a rich source of targets for therapeutic intervention and a paradigm for studying RNA processing mechanisms.
mRNA 3'-end processing At A Glance
| GO ID | GO:0031124 |
|---|---|
| GO term | mRNA 3'-end processing |
| Ontology | biological_process |
| Synonym | mRNA 3' end processing |
| Major function | Formation of the mature 3' end of mRNA via cleavage and polyadenylation |
| Key machinery | CPSF, CstF, CFI, CFII, symplekin, poly(A) polymerase |
| Cellular context | Nucleus, coupled to transcription and splicing |
| Regulation | Modulated by stress, viral infection, and condensates |
What Is GO:0031124?
According to the Gene Ontology, GO:0031124 (mRNA 3'-end processing) is defined as any process involved in forming the mature 3' end of an mRNA molecule. This includes the endonucleolytic cleavage of the pre-mRNA and the subsequent addition of a poly(A) tail, which together generate a functional 3' terminus.
Why Is mRNA 3'-end processing Important in Cell Biology?
mRNA 3'-end processing is critical because it defines the terminal structure of every eukaryotic mRNA, thereby influencing mRNA stability, export, and translational efficiency. Defects in this process can lead to aberrant gene expression and are associated with a growing list of human diseases, including cancer and neurological disorders. Moreover, the pathway is a point of convergence for cellular stress signals and viral hijacking mechanisms, making it a focal point for understanding gene regulation in health and disease.
• Essential for mRNA maturation, stability, and translation.
• Coupled to transcription and splicing, coordinating gene expression.
• Dysregulation linked to cancer, neurodegeneration, and other diseases.
• Targeted by viruses to modulate host gene expression.
• Affected by genotoxic stress, impacting RNA processing fidelity.
• Regulated by biomolecular condensates, revealing new control layers.
• Provides targets for therapeutic intervention in disease.
• Key to understanding apicomplexan parasite biology.
What Happens During mRNA 3'-end processing?
Recognition of the polyadenylation signal
In simple terms: The cell first reads a specific sequence near the end of the RNA to know where to cut.
The process begins with the recognition of the polyadenylation signal (typically AAUAAA) in the pre-mRNA by the cleavage and polyadenylation specificity factor (CPSF). This recognition is aided by other factors such as CstF, which binds to downstream U/GU-rich elements, and together they define the cleavage site.
Endonucleolytic cleavage of the pre-mRNA
In simple terms: The RNA is cut at a precise spot to create a free 3' end.
After signal recognition, the pre-mRNA is cleaved endonucleolytically by the cleavage factor I (CFI) and cleavage factor II (CFII), often in conjunction with CPSF and CstF. This cleavage generates an upstream fragment with a free 3' hydroxyl group that will receive the poly(A) tail, and a downstream fragment that is degraded.
Poly(A) tail addition
In simple terms: A string of A's is added to the cut end to protect and stabilize the mRNA.
Following cleavage, poly(A) polymerase (PAP) adds a poly(A) tail to the 3' end, using ATP as a substrate. The length of the tail is regulated by CPSF and other factors, and it is critical for mRNA stability and nuclear export.
Coupling with transcription and splicing
In simple terms: The cutting and tailing happen while the RNA is still being made and processed.
3'-end processing is physically and functionally coupled to transcription by RNA polymerase II and to splicing, ensuring that only properly processed mRNAs are produced. This coupling involves interactions between the processing machinery and the C-terminal domain of RNA polymerase II.
Regulation by stress and condensates
In simple terms: Cellular stress and tiny droplets can change how the RNA end is processed.
Genotoxic stress can alter the efficiency and site choice of 3'-end processing, impacting gene expression programs. Additionally, biomolecular condensates formed by processing factors can concentrate components and regulate the reaction in space and time.
Key Genes Involved in GO:0031124 mRNA 3'-end processing
The following genes encode core components of the mRNA 3'-end processing machinery and are frequently studied in functional and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CPSF1 | Component of CPSF, recognizes polyadenylation signal | Knockout leads to defects in cleavage and polyadenylation |
| CPSF2 | Component of CPSF, essential for cleavage | Mutations affect mRNA processing and gene expression |
| CPSF3 | Endonuclease subunit of CPSF | Target for studying cleavage mechanism |
| CPSF4 | Component of CPSF, binds RNA | Involved in signal recognition and regulation |
| CSTF1 | Component of CstF, binds downstream elements | Knockdown alters poly(A) site choice |
| CSTF2 | Component of CstF, RNA-binding | Linked to cancer and RNA processing defects |
| CSTF3 | Component of CstF, stabilizes complex | Required for efficient cleavage |
| CFI1 | Cleavage factor I subunit | Essential for endonucleolytic cleavage |
| CFI2 | Cleavage factor I subunit | Modulates cleavage efficiency |
| CFII | Cleavage factor II, interacts with CPSF | Required for cleavage and polyadenylation |
| SYMPK | Symplekin, scaffolding protein | Coordinates processing complex assembly |
| PAPOLA | Poly(A) polymerase alpha | Adds poly(A) tail, target for inhibition |
| PAPOLB | Poly(A) polymerase beta | Testis-specific, role in spermatogenesis |
| PABPN1 | Poly(A) binding protein nuclear 1 | Regulates tail length, linked to OPMD |
| CPSF6 | Component of CPSF, RNA-binding | Involved in alternative polyadenylation |
| WDR33 | Component of CPSF, recognizes AAUAAA | Critical for signal recognition |
| FIP1L1 | Component of CPSF, links PAP to CPSF | Fusion in leukemia, regulates polyadenylation |
How Is mRNA 3'-end processing Regulated?
mRNA 3'-end processing is regulated at multiple levels. Genotoxic stress can alter the recruitment of processing factors and change poly(A) site usage, impacting gene expression. Viral infections often modulate the host 3'-end processing machinery to favor viral mRNA production and inhibit host responses. Biomolecular condensates can concentrate processing components, influencing reaction kinetics and specificity. Additionally, the process is coupled to transcription and splicing, allowing for coordinated regulation.
mRNA 3'-end processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSTF2 | Cancer (alternative polyadenylation) | Knockout in cancer cell lines |
| PABPN1 | Oculopharyngeal muscular dystrophy | Knock-in of expanded alanine tract |
| CPSF6 | Cancer, viral infection | Overexpression and knockout models |
| FIP1L1 | Leukemia (fusion with PDGFRA) | Point mutation and knock-in |
| SYMPK | Cancer, RNA processing defects | Knockout and tagged knock-in |
Cancer
Dysregulation of 3'-end processing factors, such as CSTF2 and CPSF6, can lead to alternative polyadenylation and altered expression of oncogenes or tumor suppressors, contributing to cancer progression. Mutations in processing factors have been observed in various malignancies, making them potential therapeutic targets.
Neurological disorders
Expansion of the poly(A) tail and mutations in PABPN1 are linked to oculopharyngeal muscular dystrophy (OPMD), a neuromuscular disorder. Other processing defects may contribute to neurodegeneration through aberrant mRNA stability.
Viral infections
Viruses often hijack the host 3'-end processing machinery to enhance viral mRNA polyadenylation and to suppress host antiviral gene expression. Understanding these interactions can inform antiviral strategies.
Apicomplexan parasite biology
In apicomplexan parasites such as Plasmodium and Toxoplasma, 3'-end processing involves a patchwork of canonical and unusual factors, offering parasite-specific targets for intervention.
From mRNA 3'-end processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CPSF1 affect poly(A) site selection? | Knockout cell line |
| Does a point mutation in CPSF3 alter cleavage activity? | Point mutation knock-in |
| How does PABPN1 aggregation contribute to OPMD? | Knock-in of expanded repeat |
| Where does CPSF6 localize during infection? | Tagged knock-in (e.g., GFP) |
| Does overexpression of CSTF2 drive oncogenesis? | Overexpression cell model |
| Which genes are essential for 3'-end processing? | CRISPR library screening |
How to Study the mRNA 3'-end processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Poly(A) site usage and gene expression | Global analysis of 3' end processing |
| Proteomics | Protein composition and interactions | Identifying novel processing factors |
| Fluorescence microscopy | Localization and condensate formation | Studying spatial regulation |
| In vitro cleavage assay | Cleavage efficiency and accuracy | Mechanistic studies of mutants |
| Poly(A) tail length assay | Length distribution of poly(A) tails | Assessing polyadenylation activity |
| CRISPR screening | Essential genes for processing | Functional genomics |
| Ribo-seq | Translation efficiency | Linking processing to translation |
RNA sequencing (RNA-seq)
RNA-seq can map poly(A) sites and quantify changes in 3' end usage upon perturbation of processing factors. It provides a global view of alternative polyadenylation.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify components of the 3'-end processing machinery and their post-translational modifications. Affinity purification coupled to mass spectrometry reveals dynamic interactions.
Imaging and condensate analysis
Fluorescence microscopy can visualize the localization of processing factors and their condensation into biomolecular condensates under different conditions. Live-cell imaging tracks dynamics.
In vitro cleavage and polyadenylation assays
Reconstituted systems with purified factors measure cleavage and poly(A) addition activities, allowing mechanistic dissection. These assays are useful for testing mutations.
How CRISPR Can Be Used to Study GO:0031124 mRNA 3'-end processing
Knockout
CRISPR knockout of core processing genes such as CPSF1, CPSF2, or CSTF2 can reveal their essential roles in mRNA 3'-end processing and cell viability. Knockout cell lines are valuable for studying loss-of-function phenotypes.
Point Mutation
Introducing point mutations in catalytic residues of CPSF3 or PAPOLA allows precise dissection of enzymatic activities without completely abolishing protein expression. Such models help distinguish between catalytic and scaffolding functions.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of processing factors enables localization and interaction studies in live cells. Knock-in of disease-associated mutations, such as PABPN1 expansions, models human disorders.
Overexpression
Overexpression of processing factors like CSTF2 or CPSF6 can mimic oncogenic states and reveal gain-of-function effects on polyadenylation and gene expression. These models are useful for drug discovery.
How EDITGENE Supports mRNA 3'-end processing Research
Researchers studying mRNA 3'-end processing-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as altered polyadenylation, cell growth, or disease progression. CRISPR-based models provide a direct way to test causality by manipulating the genome precisely.
Contact EDITGENE today to design your custom CRISPR model for mRNA 3'-end processing research.
Frequently Asked Questions About mRNA 3'-end processing
What is mRNA 3'-end processing?
mRNA 3'-end processing (GO:0031124) is the biological process that forms the mature 3' end of an mRNA molecule through cleavage and polyadenylation.
What genes are involved in mRNA 3'-end processing?
Key genes include CPSF1, CPSF2, CPSF3, CPSF4, CSTF1, CSTF2, CSTF3, CFI1, CFI2, CFII, SYMPK, PAPOLA, PAPOLB, PABPN1, CPSF6, WDR33, and FIP1L1.
What is the function of CPSF in mRNA 3'-end processing?
CPSF recognizes the polyadenylation signal and coordinates cleavage and polyadenylation.
How is mRNA 3'-end processing regulated?
It is regulated by coupling to transcription and splicing, by cellular stress, viral infection, and biomolecular condensates.
What diseases are associated with defects in mRNA 3'-end processing?
Diseases include cancer, oculopharyngeal muscular dystrophy, and viral infections.
What is alternative polyadenylation?
Alternative polyadenylation is the use of different poly(A) sites, generating mRNA isoforms with different 3' ends, often regulated by processing factors.
How can CRISPR be used to study mRNA 3'-end processing?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of processing genes.
What methods are used to study mRNA 3'-end processing?
Methods include RNA-seq, proteomics, imaging, in vitro cleavage assays, and CRISPR screens.
Why is mRNA 3'-end processing important for gene expression?
It determines mRNA stability, export, and translation, and is coupled to transcription and splicing.
What is the role of poly(A) polymerase in 3'-end processing?
Poly(A) polymerase adds the poly(A) tail to the cleaved mRNA, a critical step for mRNA maturation.
Conclusion
mRNA 3'-end processing (GO:0031124) is a central step in gene expression that ensures the production of stable, translatable mRNAs. Its machinery is complex, highly regulated, and implicated in numerous diseases, making it a vibrant area of research. CRISPR-based models offer powerful tools to dissect the functions of processing factors and to explore therapeutic opportunities.
References
- 1. Boreikaitė V et al.. 2023. 3'-End Processing of Eukaryotic mRNA: Machinery, Regulation, and Impact on Gene Expression.. Annu Rev Biochem 92:199-225 PMID: 37001138
- 2. Kumar A et al.. 2019. Mechanistic insights into mRNA 3'-end processing.. Curr Opin Struct Biol 59:143-150 PMID: 31499460
- 3. Biswas B et al.. 2024. Genotoxic stress impacts pre-mRNA 3'-end processing.. Bioessays 46(9):e2400037 PMID: 39030821
- 4. Swale C et al.. 2023. 3'-end mRNA processing within apicomplexan parasites, a patchwork of classic, and unexpected players.. Wiley Interdiscip Rev RNA 14(5):e1783 PMID: 36994829
- 5. Vijayakumar A et al.. 2022. Modulation of mRNA 3'-End Processing and Transcription Termination in Virus-Infected Cells.. Front Immunol 13:828665 PMID: 35222412
- 6. Yoon Y et al.. 2025. Emerging Roles of Biomolecular Condensates in Pre-mRNA 3' End Processing.. Wiley Interdiscip Rev RNA 16(4):e70024 PMID: 40804711
- 7. Wahle E et al.. 1999. 3'-End processing of pre-mRNA in eukaryotes.. FEMS Microbiol Rev 23(3):277-95 PMID: 10371034
- 8. Danckwardt S et al.. 2008. 3' end mRNA processing: molecular mechanisms and implications for health and disease.. EMBO J 27(3):482-98 PMID: 18256699
